Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1214 of 6351
-
Eye implant could reduce need for frequent shots for blinding disease
Disease control Recruiting nowThis study will evaluate the long-term safety and tolerability of the Port Delivery System with ranibizumab (PDS) (100 mg/mL) in participants with neovascular age-related macular degeneration (nAMD) who have either completed Phase II Study GX28228 (Ladder), Phase III Study GR4054…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a tiny shock absorber in the knee replace the need for joint replacement?
Symptom relief CompletedA clinical study to evaluate the safety and effectiveness of the Calypso Knee System when used in subjects with symptomatic osteoarthritis of the medial compartment of the knee.
Sponsor: Moximed • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
New heart procedure aims to stop persistent AFib without pills
Disease control CompletedThe purpose of the Diamond-AF II study is to establish the safety and effectiveness of the DiamondTemp Ablation System for the treatment of drug refractory, symptomatic persistent atrial fibrillation in patients.
Sponsor: Medtronic Cardiac Ablation Solutions • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Saline vs. Ringer's: which fluid saves more lives in septic shock?
Disease control CompletedDespite evidence of the physiologic benefits and possible lower mortality associated with low chloride solutions, normal saline remains the most wildly used fluid in the world. Given uncertainty about the impact of lower chloride versus higher chloride solutions on mortality, it …
Phase 2/3 • Sponsor: McMaster University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Psoriasis drug bimekizumab shows promise in Long-Term safety trial
Disease control CompletedThis is a study to evaluate the long-term safety and tolerability of bimekizumab in adult subjects with moderate to severe chronic plaque psoriasis (PSO).
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New study seeks to sharpen Alzheimer's diagnosis with simple tests
Diagnosis Recruiting nowThe participant in this study includes Alzheimer's disease (AD including familial AD and sporadic AD) patients, amnestic mild cognitive impairment (aMCI) patients, non-AD dementia patients and cognitively normal control. The purpose of this study is to establish the best cut-off…
Sponsor: Capital Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
Could a daily aspirin protect diabetic Moms-to-Be?
Disease control CompletedTo investigate the effect of aspirin therapy initiated in the first trimester of pregnancy in women with pregestational type I or type II diabetes on a composite clinical measure of placental dysfunction (preeclampsia, preterm birth less than 34 weeks, birthweight below the 10th …
Phase 3 • Sponsor: Royal College of Surgeons, Ireland • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Dissolvable heart patch offers hope for kids with hole in the heart
Disease control CompletedThe aim of this study is to evaluate the safety and efficacy of Absnow absorbable ASD closure system for treating patients with atrial septal defect.
Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could a common cholesterol drug shrink uterine fibroids?
Disease control OngoingThe study aims to study the effect of simvastatin on the size of uterine fibroids.
Phase 2 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New pill may keep yeast infections away for good
Disease control CompletedRecurrent vulvovaginal candidiasis (RVVC), also known as recurrent yeast infections, is defined as at least 3 episodes of acute VVC in the past 12 months. Several properties of oteseconazole (VT-1161) suggest that it might be a safer and more effective treatment for RVVC than oth…
Phase 3 • Sponsor: Mycovia Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Yeast vaccine shows promise in stopping Cancer's return
Disease control CompletedThis is a phase 1 study to evaluate the safety, the Recommended Phase 2 Dose (RP2D), and preliminary efficacy of a personalized neoepitope yeast-based vaccine, YE-NEO-001, in subjects who have completed potentially curative therapy for their solid cancer and who would otherwise b…
Phase 1 • Sponsor: NantBioScience, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Engineered immune cells take on kidney cancer in early trial
Disease control OngoingBackground: Gene transfer is a new cancer therapy takes white blood cells from a person and grows them in a lab. The cells are changed with a virus to attack tumor cells, then returned to the person. Researchers want to see if this therapy fights kidney cancer cells. Objective:…
Phase 1 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Shorter radiation after breast surgery shows promise for cancer control
Disease control OngoingThis study is to evaluate the efficacy and toxicity of accelerated partial breast irradiation (ABPI) with intensity modulated radiation therapy (IMRT) in low-risk breast cancer treat with breast-conserving surgery.
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Rectal cancer: could a 'Watch and Wait' strategy spare patients from major surgery?
Disease control Stopped earlyThe purpose of this project is to determine if in a selected group of patients, at higher risk of wound dehiscence and other complications, treatment by local excision and management by a "watchful waiting" or an initial "non-operative management" approach, with an offer of radic…
Sponsor: Henry Ford Health System • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a vaccine prevent genital warts from returning after surgery?
Disease control CompletedLarge genital warts are frequently diagnosed in general gynaecology and oncology clinics in South Africa. Medical and destructive therapy for small warts is generally very effective, however unique problems posed by large or extensive genital warts are not so easily solved and tr…
Phase 3 • Sponsor: University of Pretoria • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New Catheter-Based valve repair could help heart patients avoid surgery
Disease control OngoingClinical Study of the Edwards Cardioband FIT Repair System
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Chemo-First approach aims to save rectums in early cancer trial
Disease control CompletedThe purpose of this study is to find out the effects of chemotherapy followed by less invasive surgery on patients and their early rectal cancer. The approach of this trial will be considered a success if at least 65% of participants are able to keep the rectum.
Phase 2 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Freeze or pills? new study battles persistent AF
Disease control CompletedThis is a prospective, randomized, multicenter study comparing the relative efficacy and safety of cryoablation of PVs using the Arctic Front Advance® balloon catheter with antiarrhythmic therapy in patients with persistent AF.
Phase 4 • Sponsor: Hospital San Carlos, Madrid • Aim: Disease control
Last updated Jun 26, 2026 16:56 UTC
-
Immunotherapy drug shows promise for tough brain cancers
Disease control CompletedThe objective of this study is to determine response rates (partial and complete responses) to nivolumab of recurrent or progressive IDH mutant (grades 2, 3 or 4) gliomas with prior exposure to alkylating agents.
Phase 2 • Sponsor: Fabio Iwamoto, MD • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Daily eyedrops may curb worsening nearsightedness in kids
Disease control CompletedStudy Objectives The objectives for this randomized trial are: 1. To determine the efficacy of daily low-dose atropine (0.01%) for slowing myopia progression over a two-year treatment period in children aged 5 to less than 13 years (Primary Outcome On-Treatment). 2. To determin…
Phase 3 • Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC